Harnessing natural killer T cells to advance cancer immunotherapy for solid tumors

In the fight against cancer, chimeric antigen receptor (CAR) T cell therapy has achieved notable success in treating blood cancers. However, it has been largely ineffective against solid tumors. A study demonstrates that a different immunotherapy approach utilizing natural killer T cells produced significant antitumor activity in preclinical models of solid tumors.

In the fight against cancer, chimeric antigen receptor (CAR) T cell therapy has achieved notable success in treating blood cancers. However, it has been largely ineffective against solid tumors. A study demonstrates that a different immunotherapy approach utilizing natural killer T cells produced significant antitumor activity in preclinical models of solid tumors.

Read more https://www.sciencedaily.com/releases/2024/10/241007160301.htm